Tesamorelin
Also known as: Egrifta · TH9507
A stabilized growth-hormone-releasing hormone (GHRH) analog best known for being studied in the context of reducing excess visceral abdominal fat by prompting the body’s own growth-hormone release.
Class
GHRH analog
Default unit
mg
Common route
Subcutaneous
Typical half-life
~26–38 min
Frequency
Daily
Commonly associated areas
Illustrative map of the body systems Tesamorelin is most often discussed in relation to. Relative emphasis only — not a measure of efficacy or a medical claim.
Proposed mechanisms / pathways
What is Tesamorelin?
Tesamorelin is a GHRH analog — a stabilized synthetic version of growth-hormone-releasing hormone. Rather than introducing growth hormone directly, it signals the pituitary gland to release a pulse of the body’s own growth hormone. It is most widely studied in the context of reducing excess visceral abdominal fat, and is one of the few peptides in this class to have been the subject of formal clinical research.
How it is thought to work
Tesamorelin is thought to bind the GHRH receptor on the pituitary, prompting a pulsatile release of growth hormone that, in turn, raises IGF-1. Because the structure resists rapid breakdown compared with native GHRH, it is reported to sustain that signal a little longer. The downstream effects on body composition are generally described as gradual and tied to this growth-hormone and IGF-1 axis rather than to any direct action on fat cells.
Educational only — not medical advice
This page is educational and is not a recommendation, dose, or medical claim. Tesamorelin has been studied clinically for specific indications, but nothing here suggests how it should be used — consult a qualified healthcare provider and follow the laws in your area.
Tracking Tesamorelin in LynkDose
GHRH analogs are slow-build compounds — changes in body composition unfold over weeks, not days. In LynkDose, log the dose and time each day, then layer in objective signals like waist measurements, weight, and body-composition data from Apple Health. The value of tracking is watching the visceral-fat and metabolic trend emerge across a full cycle, which a single day never shows.
Commonly discussed for
- Reduction of excess visceral abdominal fat
- Supporting the body’s natural growth-hormone pulse
- Body-composition and metabolic goals over longer timeframes
Often stacked: Sometimes discussed alongside GH-releasing peptides like Ipamorelin to pair a GHRH analog with a secretagogue, though Tesamorelin is also used on its own.
How to track Tesamorelin in LynkDose
Because effects build slowly, log the dose and time daily and pair it with waist measurements or body-composition data so the visceral-fat trend becomes visible over weeks.
Deeper read: How to Track a Peptide Cycle: A Complete Guide
Not medical advice
This page is educational and does not recommend, prescribe, or dose any compound. Many peptides are research chemicals not approved for general human use. Always consult a qualified healthcare provider and follow the laws in your area.